MEDI522

· MedImmune LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MEDI522, covering 2008-05-29 to 2008-05-29. Get the full timeline:

Most recent: Clinical Trial Update: Phase I Study of MEDI522 in Patients With Irinotecan-Refractory Advanced Colorectal Cancer [Phase 1, Phase 2]